Vilnius University Hospital Santaros Klinikos
Vilnius, 08410, Lithuania
NCT Number: NCT05621421
A single center, prospective, observational study to investigate the impact of intravascular ultrasound (IVUS) on the functional percutaneous coronary intervention (PCI) result (assessed with fractional flow reserve (FFR)) and one-year target vessel failure (TVF) rate after percutaneous treatment of long coronary artery lesions
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Vilnius, 08410, Lithuania
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
PCI to the long lesion guided with FFR and IVUS
Time frame: 1 day
Post PCI FFR value ≥ 0.9
Time frame: 1 day
If all the four following IVUS criteria met: (1) good stent apposition; (2) good stent expansion (minimal stent area (MSA) >90% of distal reference lumen area and/or MSA ≥5.5mm2); (3) plaque burden 5mm proximal and distal to the stent <50%); (4) no stent edge dissection.
Time frame: 1 day
Post PCI FFR value ≥ 0.9 and all four IVUS criteria met
Time frame: 12 months post PCI follow up
Composite endpoint (target vessel related death (TV-death), target vessel related myocardial infarction (TV-MI), ischemia driven target vessel revascularization (TV-R))
Vilnius University Hospital Santaros Klinikos
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05336435
Acute Coronary Syndrome, Angina Pectoris
Aabenraa, Denmark
View Trial DetailsNCT07480629
Antiplatelet Therapy of Coronary Artery Bypass, Arterial Occlusive Diseases
Shanghai, China
View Trial DetailsNCT05406284
Arterial Occlusive Diseases, Arteriosclerosis
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03188705
Arterial Occlusive Diseases, Arteriosclerosis
Lancaster, Pennsylvania, United States
View Trial Details